Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin GB0009252882
Ticker GSK.L
Company GLAXOSMITHKLINE
Currency £
Price
Aware Investor Index (AII) 290.7452
Recommendation STRONG BUY
P/E 44.99
ROE 100.00 %
Capitalization 293,410,164,996 $
Dividend Yield 2.09 %
P/S 9.76
AII Position 14
P/E Position 570
ROE Position 28
Capitalization Position 16
Dividend Yield Position 308
Sales 23,923,000,000 £
10-Year Average Earnings 5,192,400,000 £
Shares Outstanding 4,888,000,000
Equity 5,114,000,000 £
Dividend per Share 1 £
Industry Pharmaceutical
Country Great Britain
GLAXOSMITHKLINE Investor Relations Web Site http://www.gsk.com/investors.html







Sales:

YEAR MONTH AMOUNT
2015 12 23,923,000,000.00 £
2014 12 23,006,000,000.00 £
2013 12 26,505,000,000.00 £

Earnings:

YEAR MONTH AMOUNT
2015 12 8,422,000,000.00 £
2014 12 2,756,000,000.00 £
2013 12 5,436,000,000.00 £
2012 12 4,499,000,000.00 £
2011 12 5,208,000,000.00 £
2010 12 2,961,000,000.00 £
2009 12 6,283,000,000.00 £
2008 12 5,551,000,000.00 £
2007 12 5,310,000,000.00 £
2006 12 5,498,000,000.00 £

Equity:

YEAR MONTH AMOUNT
2015 12 5,114,000,000.00 £
2014 12 4,263,000,000.00 £
2013 12 7,812,000,000.00 £
2012 12 6,747,000,000.00 £
2011 12 8,827,000,000.00 £
2010 12 9,745,000,000.00 £
2009 12 10,742,000,000.00 £
2008 12 8,318,000,000.00 £
2007 12 9,910,000,000.00 £
2006 12 9,648,000,000.00 £

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 4,888,000,000
2014 12 4,865,000,000
2013 12 4,919,000,000
2012 12 4,913,000,000
2011 12 5,099,000,000
2010 12 5,128,000,000
2009 12 5,108,000,000
2008 12 5,226,000,000
2007 12 5,567,000,000
2006 12 5,700,000,000

 












Bloomberg News for GLAXOSMITHKLINE:



Google News for GLAXOSMITHKLINE:

Reuters UK - 1 day ago
New GlaxoSmithKline CEO wants fewer, bigger new drug launches
LONDON GlaxoSmithKline's (GSK.L) new chief executive aims to improve returns in drug development, and wants fewer but bigger new ...
Davidson Register - 18 hours ago
Investor Sphere: Keeping an Eye on Levels for GlaxoSmithKline ...
Technical traders may be looking at recent indicator levels on shares of GlaxoSmithKline PLC (GSK.L). After a recent check, the 50-day Moving Average is ...
Reuters - 20 Apr 2017
GSK must pay $3 million in generic Paxil suicide lawsuit: US jury
GlaxoSmithKline(GSK.L) must pay $3 million to a woman who sued the drug company over the death of her husband, a lawyer who committed ...
Investomania (blog) - 14 hours ago
AstraZeneca could surge higher than GlaxoSmithKline, Shire And ...
That's ahead of the performance of other pharma stocks such as GlaxoSmithKline plc (LON:GSK) (GSK.L), Shire PLC (LON:SHP) (SHP.L) and ...
Nasdaq - 1 day ago
Earnings support Britain's FTSE, StanChart leads banks higher
Heavyweight drugmaker GlaxoSmithKline <GSK.L> fell more than 2 percent after reporting first quarter figures, while Shire <SHP.L> dropped ...
Nasdaq - 3 days ago
Ghana, Kenya and Malawi to pilot GSK malaria vaccine from 2018
The injectable vaccine, called RTS,S or Mosquirix, was developed by British drugmaker GlaxoSmithKline <GSK.L> to protect children from the ...
Nasdaq - 6 days ago
Teva's new asthma inhaler poses first competition for GSK's Advair
N> on Thursday launched an asthma inhaler that will be the first direct competition to GlaxoSmithKline's <GSK.L> best-selling Advair. Teva ...
Investomania (blog) - 1 day ago
4 consumer stocks I'm bullish on: easyJet, Imperial Brands, Diageo ...
Although GlaxoSmithKline plc (LON:GSK) (GSK.L) is a healthcare company, it contains a major consumer goods arm which I feel provides it ...
Nasdaq - 2 days ago
Novartis sets sights on return to growth in 2018
S> and a joint venture with GlaxoSmithKline <GSK.L>. Jimenez is now counting on psoriasis treatment Cosentyx, chronic heart failure drug ...
Investomania (blog) - 2 days ago
easyJet and GlaxoSmithKline could be set to soar
I've been a holder of GlaxoSmithKline plc (LON:GSK) (GSK.L) since 2014. The pharmaceutical powerhouse is now trading at 1565p. With a ...


Back